PL320217A1 - Compound antagonistic in respect to tachokinin - Google Patents
Compound antagonistic in respect to tachokininInfo
- Publication number
- PL320217A1 PL320217A1 PL95320217A PL32021795A PL320217A1 PL 320217 A1 PL320217 A1 PL 320217A1 PL 95320217 A PL95320217 A PL 95320217A PL 32021795 A PL32021795 A PL 32021795A PL 320217 A1 PL320217 A1 PL 320217A1
- Authority
- PL
- Poland
- Prior art keywords
- tachokinin
- respect
- compound antagonistic
- antagonistic
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425085.9A GB9425085D0 (en) | 1994-12-13 | 1994-12-13 | Organic compounds |
| GBGB9426016.3A GB9426016D0 (en) | 1994-12-22 | 1994-12-22 | Organic compounds |
| PCT/EP1995/004910 WO1996018643A1 (en) | 1994-12-13 | 1995-12-12 | Tachykinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL320217A1 true PL320217A1 (en) | 1997-09-15 |
Family
ID=26306161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL95320217A PL320217A1 (en) | 1994-12-13 | 1995-12-12 | Compound antagonistic in respect to tachokinin |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0797583A1 (en) |
| JP (1) | JPH10511935A (en) |
| AR (1) | AR001332A1 (en) |
| AU (1) | AU4343796A (en) |
| BR (1) | BR9509997A (en) |
| CA (1) | CA2204130A1 (en) |
| CO (1) | CO4700289A1 (en) |
| CZ (1) | CZ179097A3 (en) |
| FI (1) | FI971685A7 (en) |
| HU (1) | HUT77002A (en) |
| IL (1) | IL116323A0 (en) |
| NO (1) | NO972526D0 (en) |
| PE (1) | PE38997A1 (en) |
| PL (1) | PL320217A1 (en) |
| SK (1) | SK74697A3 (en) |
| TR (1) | TR199501568A2 (en) |
| WO (1) | WO1996018643A1 (en) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117855A (en) | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| DE69736390T2 (en) * | 1996-10-07 | 2007-07-26 | Merck Sharp & Dohme Ltd., Hoddesdon | CNS PENETRATING NK-1 RECEPTOR ANTAGONISTS AS ANTIDEPRESSIVE AND / OR ANXIOLYTIC |
| JP2002542151A (en) | 1999-02-18 | 2002-12-10 | 科研製薬株式会社 | Novel amide derivatives as growth hormone secretagogues |
| MXPA02004330A (en) | 1999-11-03 | 2004-07-30 | Albany Molecular Res Inc | Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin. |
| US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
| KR100821410B1 (en) | 2000-07-11 | 2008-04-10 | 에이엠알 테크놀로지, 인크. | 4-phenyl substituted tetrahydroisoquinoline and its therapeutic use |
| NZ552397A (en) | 2004-07-15 | 2011-04-29 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| ES2382814T3 (en) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Cis-4 - [(4-chlorophenyl) sulfonyl] -4- (2,5-difluorophenyl) cyclohexanopropanoic acid for cancer treatment |
| KR101594898B1 (en) | 2005-07-15 | 2016-02-18 | 알바니 몰레큘라 리써치, 인크. | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| EP1940842B1 (en) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| US8173629B2 (en) | 2006-09-22 | 2012-05-08 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| JP4611444B2 (en) | 2007-01-10 | 2011-01-12 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | Amide substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| JP5319518B2 (en) | 2007-04-02 | 2013-10-16 | Ｍｓｄ株式会社 | Indoledione derivative |
| AU2008269154B2 (en) | 2007-06-27 | 2014-06-12 | Merck Sharp & Dohme Llc | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| AU2009222122A1 (en) | 2008-03-03 | 2009-09-11 | Tiger Pharmatech | Tyrosine kinase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| WO2010132437A1 (en) | 2009-05-12 | 2010-11-18 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| AU2010247763B2 (en) | 2009-05-12 | 2015-12-24 | Albany Molecular Research, Inc. | 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof |
| AU2010247735B2 (en) | 2009-05-12 | 2015-07-16 | Albany Molecular Research, Inc. | Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydroisoquinoline and use thereof |
| PE20121172A1 (en) | 2009-10-14 | 2012-09-05 | Merck Sharp & Dohme | PIPERIDINS SUBSTITUTED WITH ACTIVITY IN HDM2 |
| WO2011163330A1 (en) | 2010-06-24 | 2011-12-29 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
| EP3330377A1 (en) | 2010-08-02 | 2018-06-06 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina) |
| US9029341B2 (en) | 2010-08-17 | 2015-05-12 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA) |
| US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
| EP2613782B1 (en) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
| US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
| WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
| WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| AU2012245971A1 (en) | 2011-04-21 | 2013-10-17 | Piramal Enterprises Limited | A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
| EP2770987B1 (en) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
| RU2660429C2 (en) | 2012-09-28 | 2018-07-06 | Мерк Шарп И Доум Корп. | Novel compounds that are erk inhibitors |
| RS56680B1 (en) | 2012-11-28 | 2018-03-30 | Merck Sharp & Dohme | Compositions and methods for treating cancer |
| KR102196882B1 (en) | 2012-12-20 | 2020-12-30 | 머크 샤프 앤드 돔 코포레이션 | Substituted imidazopyridines as hdm2 inhibitors |
| WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| WO2015034925A1 (en) | 2013-09-03 | 2015-03-12 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| EP3525785B1 (en) | 2016-10-12 | 2025-08-27 | Merck Sharp & Dohme LLC | Kdm5 inhibitors |
| US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
| EP3706747B1 (en) | 2017-11-08 | 2025-09-03 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| US12173026B2 (en) | 2018-08-07 | 2024-12-24 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
| EP3833668B1 (en) | 2018-08-07 | 2025-03-19 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164372A (en) * | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
| JPH05186498A (en) * | 1991-12-27 | 1993-07-27 | Japan Tobacco Inc | Proline derivative |
-
1995
- 1995-12-11 PE PE1995286859A patent/PE38997A1/en not_active Application Discontinuation
- 1995-12-11 IL IL11632395A patent/IL116323A0/en unknown
- 1995-12-12 CZ CZ971790A patent/CZ179097A3/en unknown
- 1995-12-12 EP EP95942131A patent/EP0797583A1/en not_active Withdrawn
- 1995-12-12 HU HU9701897A patent/HUT77002A/en unknown
- 1995-12-12 CO CO95058767A patent/CO4700289A1/en unknown
- 1995-12-12 WO PCT/EP1995/004910 patent/WO1996018643A1/en not_active Ceased
- 1995-12-12 SK SK746-97A patent/SK74697A3/en unknown
- 1995-12-12 AU AU43437/96A patent/AU4343796A/en not_active Abandoned
- 1995-12-12 JP JP8518261A patent/JPH10511935A/en active Pending
- 1995-12-12 FI FI971685A patent/FI971685A7/en not_active Application Discontinuation
- 1995-12-12 CA CA002204130A patent/CA2204130A1/en not_active Abandoned
- 1995-12-12 PL PL95320217A patent/PL320217A1/en unknown
- 1995-12-12 BR BR9509997A patent/BR9509997A/en not_active Application Discontinuation
- 1995-12-13 AR AR33458995A patent/AR001332A1/en unknown
- 1995-12-13 TR TR95/01568A patent/TR199501568A2/en unknown
-
1997
- 1997-06-03 NO NO972526A patent/NO972526D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0797583A1 (en) | 1997-10-01 |
| AU4343796A (en) | 1996-07-03 |
| WO1996018643A1 (en) | 1996-06-20 |
| FI971685L (en) | 1997-08-13 |
| MX9703957A (en) | 1997-09-30 |
| TR199501568A2 (en) | 1996-07-21 |
| CZ179097A3 (en) | 1997-10-15 |
| FI971685A0 (en) | 1997-04-18 |
| BR9509997A (en) | 1997-12-30 |
| PE38997A1 (en) | 1997-10-02 |
| FI971685A7 (en) | 1997-08-13 |
| IL116323A0 (en) | 1996-03-31 |
| HUT77002A (en) | 1998-03-02 |
| SK74697A3 (en) | 1997-11-05 |
| CO4700289A1 (en) | 1998-12-29 |
| JPH10511935A (en) | 1998-11-17 |
| CA2204130A1 (en) | 1996-06-20 |
| AR001332A1 (en) | 1997-10-22 |
| NO972526L (en) | 1997-06-03 |
| NO972526D0 (en) | 1997-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL320217A1 (en) | Compound antagonistic in respect to tachokinin | |
| GB2321004B (en) | Improvements in or relating to enclosures | |
| GB9403997D0 (en) | Improvements relating to workpiece trimmers | |
| GB9401513D0 (en) | Improvements in or relating to tools | |
| GB2265069B (en) | Improvements in or relating to networks | |
| GB9416370D0 (en) | Improvements relating to surfaces | |
| PL319904A1 (en) | Nitrobenzamides useful as antiarrythimic agents | |
| GB9508602D0 (en) | Improvements in or relating to rheology | |
| GB9418205D0 (en) | Improvements relating to strimmers | |
| GB9310293D0 (en) | Improvements in or relating to loudspeakers | |
| GB9402677D0 (en) | Improvements to tape measures | |
| GB9426105D0 (en) | Improvements relating to electrolevels | |
| GB2285480B (en) | Improvements relating to fasteners | |
| GB9312738D0 (en) | Improvements relating to trackerballs | |
| GB9724471D0 (en) | Improvements relating to planers | |
| EP0790832A4 (en) | Topical preparation | |
| GB9505543D0 (en) | Rake | |
| ZA958534B (en) | Multi-purpose pan-stove | |
| GB9820388D0 (en) | Improvements relating to furniture | |
| GB9415649D0 (en) | Improvements relating to roofracks | |
| GB9401711D0 (en) | Improvements relating to mocro-analytical techniques | |
| GB9414592D0 (en) | Improvements relating to loe-friction members | |
| GB9419240D0 (en) | Improvements in or relating to handpumps | |
| GB9426190D0 (en) | Improvements relating to hold-all luggage | |
| GB9425620D0 (en) | Improvements relating to decorative surfaces |